Compounds > clarithromycin
Page last updated: 2024-08-25

clarithromycin and Diffuse Parenchymal Lung Disease

clarithromycin has been researched along with Diffuse Parenchymal Lung Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cinotti, E; Fimiani, M; Rubegni, P; Tognetti, L1
Hermansen, MN; Schmidt, BJ1
Choi, YW; Jeon, SC; Kim, H; Kim, TH; Paik, SS; Park, DW; Park, SS; Shon, JW; Yoon, HJ1
Corkey, R; Joiner, J; Knyazhitskiy, A; Masson, RG1
Abdullah, MF; O'Connor, MB; O'Donovan, N; Phelan, MJ1
Caulet-Maugendre, S; Delaval, P; Desrues, B; Guillot, S; Jouneau, S; Kerjouan, M; Meunier, C1
Hata, K; Hisamori, S; Inoue, T; Ishimaru, H; Katoh, K; Maeda, Y; Maniwa, K; Minaguchi, M; Oida, K; Sakuramoto, M; Taguchi, Y; Tanaka, E; Terada, K1

Other Studies

7 other study(ies) available for clarithromycin and Diffuse Parenchymal Lung Disease

ArticleYear
Bullous impetigo during interstitial pneumonitis.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2017, Volume: 152, Issue:6

    Topics: Anti-Bacterial Agents; Blister; Child; Clarithromycin; Diagnosis, Differential; Drug Eruptions; Humans; Impetigo; Lung Diseases, Interstitial; Male; Penicillin Resistance; Pneumonia, Mycoplasma; Staphylococcus aureus

2017
[Late debut of neonatal pneumonia caused by Chlamydia trachomatis].
    Ugeskrift for laeger, 2013, Feb-18, Volume: 175, Issue:8

    Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Chlamydial Pneumonia; Clarithromycin; Humans; Infant; Lung Diseases, Interstitial; Male; Radiography; Respiratory Syncytial Virus, Human; Time Factors

2013
Near fatal desquamative interstitial pneumonia with bilateral recurrent tension pneumothorax.
    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2015, Jul-22, Volume: 32, Issue:2

    Topics: Adult; Biopsy, Needle; Clarithromycin; Combined Modality Therapy; Critical Illness; Disease Progression; Follow-Up Studies; Genetic Diseases, Inborn; Humans; Lung Diseases, Interstitial; Male; Multidetector Computed Tomography; Pneumothorax; Prednisolone; Rare Diseases; Recurrence; Risk Assessment; Thoracic Surgery, Video-Assisted; Treatment Outcome

2015
Beneficial response to macrolide antibiotic in a patient with desquamative interstitial pneumonia refractory to corticosteroid therapy.
    Chest, 2008, Volume: 134, Issue:1

    Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Lung Diseases, Interstitial; Macrolides; Middle Aged

2008
Rituximab-induced pulmonary disease.
    Rheumatology international, 2012, Volume: 32, Issue:9

    Topics: Amoxicillin-Potassium Clavulanate Combination; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis; Clarithromycin; Drug Therapy, Combination; Humans; Hydrocortisone; Lung Diseases, Interstitial; Male; Middle Aged; Prednisolone; Rituximab; Treatment Outcome

2012
Clarithromycin stops lung function decline in airway-centered interstitial fibrosis.
    Respiration; international review of thoracic diseases, 2013, Volume: 85, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Esomeprazole; Glucocorticoids; Humans; Lung Diseases, Interstitial; Male; Prednisolone; Pulmonary Fibrosis; Radiography; Respiratory Function Tests; Treatment Failure

2013
[A case of pulmonaly bulla infection with Mycobacterium fortuitum].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2003, Volume: 77, Issue:6

    Topics: Aged; Blister; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Lung Diseases, Interstitial; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Pulmonary Emphysema

2003